Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.9M Buy
74,481
+4,280
+6% +$561K 1.64% 21
2025
Q4
$9.56M Sell
70,201
-108
-0.2% -$15.5K 1.81% 20
2025
Q3
$10.4M Sell
70,309
-5
-0% -$693 1.97% 21
2025
Q2
$9.1M Sell
70,314
-3,852
-5% -$467K 1.8% 21
2025
Q1
$8.86M Sell
74,166
-470
-0.6% -$58.2K 1.8% 22
2024
Q4
$8.66M Buy
74,636
+3,286
+5% +$415K 1.7% 23
2024
Q3
$9.63M Sell
71,350
-200
-0.3% -$26.8K 1.89% 23
2024
Q2
$9.7M Buy
71,550
+1,337
+2% +$182K 1.98% 23
2024
Q1
$9.07M Buy
70,213
+763
+1% +$92.2K 1.94% 23
2023
Q4
$7.94M Buy
69,450
+3,690
+6% +$368K 1.98% 23
2023
Q3
$5.99M Buy
65,760
+1,442
+2% +$149K 1.65% 26
2023
Q2
$7.24M Buy
64,318
+1,075
+2% +$114K 1.91% 23
2023
Q1
$6.62M Buy
63,243
+264
+0.4% +$27.6K 1.86% 23
2022
Q4
$6.96M Buy
62,979
+431
+0.7% +$45.2K 2.07% 22
2022
Q3
$5.46M Buy
62,548
+184
+0.3% +$16.7K 1.71% 26
2022
Q2
$4.87M Buy
62,364
+55
+0.1% +$4.54K 1.48% 29
2022
Q1
$5.31M Buy
62,309
+691
+1% +$66.2K 1.36% 31
2021
Q4
$7.39M Sell
61,618
-1,150
-2% -$143K 1.78% 23
2021
Q3
$7.76M Buy
62,768
+145
+0.2% +$18.7K 2.07% 20
2021
Q2
$7.51M Buy
62,623
+498
+0.8% +$56.9K 2% 20
2021
Q1
$6.53M Buy
62,125
+232
+0.4% +$23.5K 1.88% 22
2020
Q4
$6.3M Buy
61,893
+1,664
+3% +$156K 1.87% 21
2020
Q3
$5.07M Buy
60,229
+2,076
+4% +$162K 1.61% 24
2020
Q2
$3.78M Sell
58,153
-82
-0.1% -$5.41K 1.26% 35
2020
Q1
$3.79M Buy
58,235
+150
+0.3% +$11.8K 1.5% 27
2019
Q4
$4.58M Buy
58,085
+30
+0.1% +$2.33K 1.48% 29
2019
Q3
$4.62M Buy
58,055
+135
+0.2% +$10.6K 1.59% 25
2019
Q2
$4.84M Buy
57,920
+105
+0.2% +$8.37K 1.69% 26
2019
Q1
$4.57M Buy
57,815
+2,930
+5% +$214K 1.63% 25
2018
Q4
$3.66M Sell
54,885
-170
-0.3% -$11.8K 1.54% 28
2018
Q3
$4.4M Sell
55,055
-80
-0.1% -$5.97K 1.49% 28
2018
Q2
$3.72M Sell
55,135
-720
-1% -$52.3K 1.36% 32
2018
Q1
$4.3M Sell
55,855
-150
-0.3% -$11.1K 1.61% 27
2017
Q4
$3.82M Sell
56,005
-3,665
-6% -$243K 1.39% 30
2017
Q3
$3.74M Buy
59,670
+3,650
+7% +$218K 1.35% 30
2017
Q2
$3.11M Buy
56,020
+10
+0% +$521 1.15% 32
2017
Q1
$2.81M Buy
56,010
+50
+0.1% +$2.44K 1.15% 32
2016
Q4
$2.77M Hold
55,960
1.2% 30
2016
Q3
$2.94M Sell
55,960
-225
-0.4% -$11K 1.25% 29
2016
Q2
$2.51M Buy
56,185
+640
+1% +$27.8K 1.06% 33
2016
Q1
$2.27M Buy
55,545
+1,390
+3% +$51.2K 0.98% 34
2015
Q4
$1.98M Buy
54,155
+1,945
+4% +$70.3K 0.88% 39
2015
Q3
$1.71M Sell
52,210
-1,450
-3% -$48.8K 0.79% 42
2015
Q2
$1.99M Buy
53,660
+95
+0.2% +$3.46K 0.85% 42
2015
Q1
$1.88M Buy
53,565
+10,935
+26% +$386K 0.78% 45
2014
Q4
$1.62M Buy
42,630
+13,685
+47% +$501K 0.69% 51
2014
Q3
$1.03M Buy
28,945
+10,770
+59% +$400K 0.46% 62
2014
Q2
$710K Buy
+18,175
New +$679K 0.33% 65

Other funds holding XYL

Brian C. Broderick's XYL Position: Q1 2026 in Review

Brian C. Broderick increased its Xylem (XYL) stake by 6.1% in Q1 2026, buying an estimated $561K and bringing the position to 74,481 shares worth $8.9M. The position accounts for 1.64% of the portfolio, ranked #21.

Brian C. Broderick first reported a position in XYL in Q2 2014 and has held it in 48 quarters since. The position peaked at $10.4M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Brian C. Broderick held 74,481 shares of Xylem worth $8.9M as of Q1 2026.
  • Brian C. Broderick bought 4,280 Xylem shares in Q1 2026, an estimated $561K.
  • Xylem made up 1.64% of Brian C. Broderick's portfolio in Q1 2026, its #21 holding.
  • Brian C. Broderick first reported a position in Xylem in Q2 2014 and has held it in 48 quarters since.
  • Brian C. Broderick's Xylem position peaked at $10.4M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.